Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2000
05/04/2000CA2348989A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348835A1 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2348827A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348747A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348730A1 Novel g protein coupled receptor protein and dna thereof
05/04/2000CA2348634A1 Methods for killing tumor and tumor associated endothelial cells using adenoviral mutants
05/04/2000CA2348563A1 Compositions and methods for treating polycystic kidney disease
05/04/2000CA2348431A1 Interleukin-1 homolog zil1a4
05/04/2000CA2348430A1 Ovary-specific genes and proteins
05/04/2000CA2348046A1 Lysine-rich statherin protein
05/04/2000CA2348019A1 Method and composition for modulating amyloidosis
05/04/2000CA2347993A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000CA2347983A1 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000CA2347828A1 Methods for enhancing wound healing
05/04/2000CA2347655A1 Growth factor related molecules
05/04/2000CA2347294A1 Novel g protein coupled receptor protein, dna and its ligand
05/04/2000CA2347293A1 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000CA2347107A1 Bone-pathobolism treating agent
05/04/2000CA2347075A1 Cdna sequence and genomic organization for a 59.4 kda neuronal-specific 7 transmembrane protein (pneu60)
05/04/2000CA2347068A1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000CA2346996A1 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
05/04/2000CA2346872A1 Preventives/remedies for liver diseases
05/04/2000CA2346387A1 Enzyme-based fungicide composition
05/04/2000CA2344606A1 Conformation-specific anti-von willebrand factor antibodies
05/04/2000CA2344207A1 Biological material for preparing pharmaceutical compositions for treating mammals
05/04/2000CA2342337A1 Vaporizing device for administering sterile medication
05/04/2000CA2316836A1 Identification of novel substrate i-traf of ikk-i kinase
05/04/2000CA2249648A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
05/03/2000EP0997477A2 MHC complexes and uses thereof
05/03/2000EP0997475A1 Tumor necrosis factor inhibitory protein TIP-B1 and method of using same
05/03/2000EP0997474A1 Antithrombotic agents
05/03/2000EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds
05/03/2000EP0997152A1 Remedies for lymphocytic tumors
05/03/2000EP0997151A2 Method for administering insulinotropic peptides
05/03/2000EP0997150A1 Preventive and therapeutic compositions for drug induced nephropathy and hepatitis
05/03/2000EP0997147A1 Amino acid derivatives
05/03/2000EP0997145A1 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
05/03/2000EP0996858A2 Interactions of atm, atr or dna-pk with p53
05/03/2000EP0996857A2 Cancer associated nucleic acids and polypeptides
05/03/2000EP0996739A2 Improvments in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10
05/03/2000EP0996733A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human
05/03/2000EP0996732A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
05/03/2000EP0996728A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES
05/03/2000EP0996726A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
05/03/2000EP0996725A1 Human nk-3 related prostate specific gene-1
05/03/2000EP0996723A1 Human phosphatidylinositol transfer protein gamma
05/03/2000EP0996721A2 Secreted proteins and polynucleotides encoding them
05/03/2000EP0996720A2 Use of pea3 in tumor suppression
05/03/2000EP0996717A2 Immunoprotective influenza antigen and its use in vaccination
05/03/2000EP0996716A1 Zggbp1,novel peptides related to bipolar affective disorder type 1, sequences and uses thereof
05/03/2000EP0996710A1 Component of bromelain
05/03/2000EP0996709A1 INHIBITORS OF CELLULOLYTIC, XYLANOLYTIC AND $g(b)-GLUCANOLYTIC ENZYMES
05/03/2000EP0996638A2 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
05/03/2000EP0996637A1 Recombinant protein c and protein s variants
05/03/2000EP0996636A1 The ha-1 antigen
05/03/2000EP0996635A1 Novel family of pheromone receptors
05/03/2000EP0996634A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use
05/03/2000EP0996633A1 Anti-inflammatory peptides derived from c-reactive protein
05/03/2000EP0996632A1 Angiostatin fragments and method of use
05/03/2000EP0996630A2 Irs-p53h, human insulin receptor tyrosine kinase substrate
05/03/2000EP0996629A2 Disulfide crosslinked glycoprotein hormone analogs, their preparation and use
05/03/2000EP0996619A1 Tropane analogs and methods for inhibition of monoamine transport
05/03/2000EP0996468A1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
05/03/2000EP0996467A1 Txu-7-pap immunotoxin and use thereof
05/03/2000EP0996463A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions
05/03/2000EP0996462A1 Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
05/03/2000EP0996461A1 Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules
05/03/2000EP0996460A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF $g(a)v$g(b)6
05/03/2000EP0996459A1 Use of exendins and agonists thereof for the reduction of food intake
05/03/2000EP0996458A1 Sandramycin analogs
05/03/2000EP0996457A1 Fsh-releasing peptides
05/03/2000EP0996456A1 Methods for treating neurological deficits
05/03/2000EP0996455A1 $g(a)-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF
05/03/2000EP0996453A1 Methods for the inhibition of neuronal activity by local delivery of adenosine
05/03/2000EP0996450A2 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
05/03/2000EP0996409A1 Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor
05/03/2000EP0961801A4 Monomers derived from hydroxy acids and polymers prepared therefrom
05/03/2000EP0812204A4 Codominance-mediated toxins
05/03/2000EP0776334A4 Stable analogs of bioactive peptides containing disulfide linkages
05/03/2000EP0721465B1 Glutathione s-transferase-activated compounds
05/03/2000EP0691985B1 Phosphonomethyldipeptides
05/03/2000EP0669977B1 Transformed endothelial cells
05/03/2000EP0652768B1 A pharmaceutical preparation for the synergistic activation of natural killer cells
05/03/2000EP0624100B1 Dna encoding a human serotonin receptor (5-ht 4b) and uses thereof
05/03/2000EP0560947B1 Trivalent monospecific antigen binding proteins
05/03/2000EP0514481B1 Merosin, nucleic acids encoding, fragments and uses thereof
05/03/2000EP0383803B1 Oligonucleotide-polyamide conjugates
05/03/2000CN1252101A Component of bromelain
05/03/2000CN1252099A Methods and compositions for synthesis of long chain polyunsaturated fatty acids
05/03/2000CN1252096A Component of bromelain
05/03/2000CN1252076A Production of antihuman antigen receptors and use thereof
05/03/2000CN1252075A Synthetic HIV GAG genes
05/03/2000CN1252074A Stimulation of red blood cell production
05/03/2000CN1252001A Method for destroying retinal pigment epithelial cells
05/03/2000CN1251996A Combination therapy for HIV infections
05/03/2000CN1251986A Diffusional implantable delivery system
05/03/2000CN1251969A Method for treating parillomarvirus infections
05/03/2000CN1251838A Samatotropin releasing peptide
05/03/2000CN1251772A Process for extracting granulocyte stimulating factor and its compound polyose capsules
1 ... 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 2417 ... 3163